NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
22 October 2024
| Name: | SUDA LTD (SUD) (This company subsequently changed its name to AROVELLA THERAPEUTICS LIMITED. You should refer to that name for Status.) | |||||||||
| Date of Listing: | 24 January 2002 | |||||||||
| Subsequent Names: |
| |||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to AROVELLA THERAPEUTICS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to AROVELLA THERAPEUTICS LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now AROVELLA THERAPEUTICS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| AROVELLA THERAPEUTICS LIMITED | 25/10/2021 | |
| SUDA PHARMACEUTICALS LTD | 05/12/2017 | 25/10/2021 |
| SUDA LTD | 07/12/2012 | 05/12/2017 |
| EASTLAND MEDICAL SYSTEMS LTD | 07/12/2012 |
Advanced Share Registry Services
110 Stirling Hwy, Nedlands WA 6009
Tel : +61 8 9389 8033
Fax : +61 8 9262 3723
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Suda Pharmaceuticals Ltd | 05/12/2017 |
The securities of Suda Ltd will be reinstated to official quotation immediately following the release of an announcement regarding negotiations with the estate of HC Berlin Pharma. | 27/02/2017 |
Discussions with the receiver for HC Berlin Pharma estate have been constructive following a recent ruling in the German courts. | 27/02/2017 |
The company requests an extension to the voluntary suspension as it awaits completion of its review in relation to the matter with the estate of HC Berlin Pahrma. It is anticipated that an announcement updating the market will be made on or before Monday, 27 February 2017. | 20/02/2017 |
The company has received a refund of $0.86 million from the Australian Taxation Office under the R&D Tax Incentive for eligible expenditure for the 2016 financial year. | 16/02/2017 |
The company requests an extension to the voluntary suspension as it awaits completion of its review in relation to the matter with the estate of HC Berlin Pharma. It is anticipated that an announcement updating the market will be made on or before Monday, 20 February 2017. | 10/02/2017 |
The company lodges its Appendix 4C - quarterly report. | 01/02/2017 |
The securities of Suda Ltd will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement regarding an estate settlement. | 27/01/2017 |
name changed from Eastland Medical Systems Ltd | 07/12/2012 |
name changed to Suda Pharmaceuticals Ltd | 05/12/2017 |
The securities of Suda Ltd will be reinstated to official quotation immediately following the release of an announcement regarding negotiations with the estate of HC Berlin Pharma. | 27/02/2017 |
Discussions with the receiver for HC Berlin Pharma estate have been constructive following a recent ruling in the German courts. | 27/02/2017 |
The company requests an extension to the voluntary suspension as it awaits completion of its review in relation to the matter with the estate of HC Berlin Pahrma. It is anticipated that an announcement updating the market will be made on or before Monday, 27 February 2017. | 20/02/2017 |
The company has received a refund of $0.86 million from the Australian Taxation Office under the R&D Tax Incentive for eligible expenditure for the 2016 financial year. | 16/02/2017 |
The company requests an extension to the voluntary suspension as it awaits completion of its review in relation to the matter with the estate of HC Berlin Pharma. It is anticipated that an announcement updating the market will be made on or before Monday, 20 February 2017. | 10/02/2017 |
The company lodges its Appendix 4C - quarterly report. | 01/02/2017 |
The securities of Suda Ltd will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement regarding an estate settlement. | 27/01/2017 |
name changed from Eastland Medical Systems Ltd | 07/12/2012 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 23/11/2017 | Michael Stewart | 588,110 | $0.019 | $11,174 |
| 15/11/2017 | Stephen Carter | 882,568 | $0.018 | $15,886 |
| 09/11/2017 | Stephen Carter | 517,432 | $0.017 | $8,796 |
| 02/11/2017 | Joseph Ohayon | 500,000 | $0.017 | $8,352 |
| 28/04/2016 | Michael Stewart | 928,556 | $0.018 | $16,714 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Michael Stewart | Non Exec Chairman | 11/06/2009 |
| Stephen Carter | CEO | 26/10/2010 |
| Joseph Ohayon | Executive Director, CFO | 01/07/2010 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Ken Robson | Non Exec Director | 08/03/2013 | 07/08/2014 |
| Peter Jooste | Non Exec Chairman | 03/07/2006 | 30/11/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
